SCHEMBL446130

SCHEMBL446130

Cc1ccc(CC[Si](C)(Cl)Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
CYP2A6 P11509 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
IDO1 P14902 1/20 0.41
HRH3 Q9Y5N1 1/20 0.39
KCNH2 Q12809 1/20 0.39
IGF1R P08069 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP19A1 P11511 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
AGXT P21549 2/20 0.37
CNR1 P21554 1/20 0.37
ACHE P22303 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899074 0.91 CA2 (0.35) CYP1A2CYP2A6TAAR1HRH3NPC1
SCHEMBL11207430 0.84 CYP1A2 (0.50) CYP1A2CYP2A6TAAR1IDO1HRH3
SCHEMBL840528 0.84 CYP1A2 (0.50) CYP1A2CYP2A6TAAR1IDO1HRH3
SCHEMBL4848522 0.82 CA2 (0.34) TAAR1
SCHEMBL8718611 0.82 LPL (0.43) NPC1RAB9ACNR1MAPTALDH1A1
SCHEMBL24602755 0.81 CYP1A2 (0.52) CYP1A2CYP2A6TAAR1IDO1HRH3
SCHEMBL523393 0.79 TDP1 (0.48) CYP1A2CYP2A6TAAR1IDO1KCNH2
SCHEMBL14078071 0.78 CYP1A2 (0.45) CYP1A2CYP2A6TAAR1IDO1HRH3
SCHEMBL11216125 0.77 LMNA (0.48) CYP1A2CYP2A6TAAR1NPC1RAB9A
SCHEMBL9231420 0.76 CYP1A2 (0.46) CYP1A2CYP2A6TAAR1IDO1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070087025-A1 Reiteratively layered medical devices and method of preparing same FITZHUGH ANTHONY 2007-04-19 US claimed
US-20060110351-A1 Use of silanes on cosmetic agents and methods for treating hair ITN NANOVATION AG (DE) 2006-05-25 US claimed
EP-1555990-A1 USE OF SILANES IN COSMETIC AGENTS AND METHODS FOR TREATING HAIR ITN NANOVATION GMBH (DE) 2005-07-27 EP claimed
EP-1436018-A1 NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2004-07-14 EP claimed
WO-2004012691-A1 USE OF SILANES IN COSMETIC AGENTS AND METHODS FOR TREATING HAIR ITN NANOVATION GMBH (DE) 2004-02-12 WO claimed
US-6632805-B1 With polyol containing at least three hydroxy groups and is not hydroxyethyl cellulose; treating food or medical articles EMORY UNIVERSITY 2003-10-14 US claimed
WO-2003026717-A1 NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2003-04-03 WO claimed
EP-0853482-A4 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE UNIV EMORY (US) 2002-07-31 EP claimed
US-6221944-B1 SURFACE TREATMENT EMORY UNIVERSITY 2001-04-24 US claimed
US-6113815-A HYDROLYSIS RESISTANCE BIOSHIELD TECHNOLOGIES, INC. (US) 2000-09-05 US claimed
EP-0996624-A1 WATER-STABILIZED ORGANOSILANE COMPOUNDS AND METHODS FOR USING THE SAME Bioshield Technologies, Inc. (US) 2000-05-03 EP claimed
US-6046293-A Solid-liquid phase interfacial polymerization UNIVERSITY OF SOUTH AUSTRALIA (AU) 2000-04-04 US claimed
US-5959014-A A REACTION PRODUCT OF AN ORGANOSILANE COMPOUND AND A POLYOL COMPOUND FOR TREATING VARIOUS SUBSTRATES; NON-TOXIC, NON-FLAMMABLE, SIMPLE, ECONOMICAL AND ARE OPERABLE OVER A WIDE VARIETY OF PH RANGES; ANTIMICROBIAL PROTECTIVE COATINGS EMORY UNIVERSITY (US) 1999-09-28 US claimed
WO-1999003865-A1 WATER-STABILIZED ORGANOSILANE COMPOUNDS AND METHODS FOR USING THE SAME BIOSHIELD TECHNOLOGIES, INC. (US) 1999-01-28 WO claimed
EP-0877027-A2 Water-stabilized organosilane compounds and methods for using the same Bioshield Technologies, Inc. (US) 1998-11-11 EP claimed
EP-0853482-A1 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE EMORY UNIVERSITY (US) 1998-07-22 EP claimed
WO-1997041876-A1 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE EMORY UNIVERSITY (US) 1997-11-13 WO claimed
EP-0799851-A2 Preparation of polyorganosilloxanes by interfacial polymerization DOW CORNING CORPORATION (US) 1997-10-08 EP claimed
US-5629401-A Preparation of polyorganosiloxanes by interfacial polymerization DOW CORNING CORPORATION (US) 1997-05-13 US claimed
EP-3743464-B1 ORGANIC-INORGANIC AEROGEL COMPOSITES, METHODS AND USES THEREOF BRONX CREATIVE&DESIGN CENTRE PTE LTD (SG) 2024-03-06 EP disclosed
US-20230250250-A1 Organic-inorganic Aerogel Composites, Methods and Uses Thereof BRONX CREATIVE & DESIGN CENTRE PTE LTD (SG) 2023-08-10 US disclosed
US-20220016292-A1 Antiviral Compound with UV Reflectivity DE NOVA TECHNOLOGY INC. 2022-01-20 US disclosed
EP-3743464-A1 ORGANIC-INORGANIC AEROGEL COMPOSITES, METHODS AND USES THEREOF Bronx Creative&Design Centre Pte Ltd (SG) 2020-12-02 EP disclosed
WO-2019147183-A1 ORGANIC-INORGANIC AEROGEL COMPOSITES, METHODS AND USES THEREOF BRONX CREATIVE & DESIGN CENTRE PTE LTD (SG) 2019-08-01 WO disclosed
US-9175141-B2 Cyclosiloxane-substituted polysiloxane compounds, compositions containing the compounds and methods of use thereof BIOFILM IP, LLC (US) 2015-11-03 US disclosed
US-8999363-B2 Methods and compositions for antimicrobial surfaces SISHIELD TECHNOLOGIES, INC. (US) 2015-04-07 US disclosed
US-8999357-B2 Methods and compositions for biocidal treatments SISHIELD TECHNOLOGIES, INC. (US) 2015-04-07 US disclosed
EP-2601245-A1 CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF Biofilm IP, LLC (US) 2013-06-12 EP disclosed
US-8404584-B2 Method of manufacturing semiconductor device FUJITSU LIMITED (JP) 2013-03-26 US disclosed
US-8273726-B2 Compositions for treating and/or preventing diseases characterized by the presence of metal ions BRANDEIS UNIVERSITY (US) 2012-09-25 US disclosed
US-8164166-B2 Interfacial roughness reducing film, wiring layer, semiconductor device, and method of manufacturing semiconductor device FUJITSU LIMITED (JP) 2012-04-24 US disclosed
US-20120064022-A1 CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF BIOFILM, INC. 2012-03-15 US disclosed
WO-2012018403-A1 CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF BIOFILM IP, LLC (US) 2012-02-09 WO disclosed
US-20110207319-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE FUJITSU LIMITED (JP) 2011-08-25 US disclosed
US-7851459-B2 Methods for diluting water-stabilized antimicrobial organosilane compositions VITEC SPECIALITY CHEMICALS LIMITED (GB) 2010-12-14 US disclosed
US-20100184724-A1 COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF METAL IONS GRENPHARMA LLC (US) 2010-07-22 US disclosed
US-7732395-B2 Water-stabilized antimicrobial organosilane products, compositions, and methods for using the same VITEC SPECIALTY CHEMICALS LTD. (GB) 2010-06-08 US disclosed
US-7632797-B2 Water-stabilized antimicrobial organosilane products, compositions, and methods for using the same VITEC SPECIALITY CHEMICALS LIMITED (GB) 2009-12-15 US disclosed
US-7595308-B2 Treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using organosilicon compounds such as dichlorodiethylsilane GRENPHARMA LLC (US) 2009-09-29 US disclosed
US-20090203644-A1 Compositions for treating and/or preventing diseases characterized by the presence of metal ions GRENPHARMA LLC (US) 2009-08-13 US disclosed
US-20090085170-A1 INTERFACIAL ROUGHNESS REDUCING FILM, WIRING LAYER, SEMICONDUCTOR DEVICE, AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE FUJITSU LIMITED (JP) 2009-04-02 US disclosed
US-20090074971-A1 Water-Stabilized Antimicrobial Organosilane Compositions, and Methods for Using the Same VITEC SPECIALITY CHEMICALS LIMITED (GB) 2009-03-19 US disclosed
WO-2009030641-A1 WATER-STABILIZED ANTIMICROBIAL ORGANOSILANE COMPOSITIONS, AND METHODS FOR USING THE SAME VITEC SPECIALITY CHEMICALS LIMITED (GB) 2009-03-12 WO disclosed
WO-2009030640-A1 METHODS FOR DILUTING WATER-STABILIZED ANTIMICROBIAL ORGANOSILANE COMPOSITIONS VITEC SPECIALITY CHEMICALS LIMITED (GB) 2009-03-12 WO disclosed
US-20090069270-A1 Methods for Diluting Water-Stabilized Antimicrobial Organosilane Compositions VITEC MICROGENIX LIMITED (GB) 2009-03-12 US disclosed
EP-2007205-A2 WATER-STABILISED ANTIMICROBIAL ORGANOSILANE PRODUCTS, COMPOSITIONS, AND METHODS FOR USING THE SAME VITEC SPECIALITY CHEMICALS LIMITED (GB) 2008-12-31 EP disclosed
EP-1887863-A2 METHODS AND COMPOSITIONS FOR BIOCIDAL TREATMENTS SiShield Technologies (US) 2008-02-20 EP disclosed
US-20070237901-A1 Water-Stabilized Antimicrobial Organosilane Products, Compositions, and Methods for Using the Same VITEC MICROGENIX LIMITED (GB) 2007-10-11 US disclosed
WO-2007099144-A2 WATER-STABILISED ANTIMICROBIAL ORGANOSILANE PRODUCTS, COMPOSITIONS, AND METHODS FOR USING THE SAME VITEC SPECIALITY CHEMICALS LIMITED (GB) 2007-09-07 WO disclosed
US-20070087025-A1 Reiteratively layered medical devices and method of preparing same FITZHUGH ANTHONY 2007-04-19 US disclosed
US-20070065475-A1 Methods and compositions for antimicrobial surfaces TERMPRO, LLC 2007-03-22 US disclosed
US-20070014828-A1 Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same GOVERNMENT OF THE USA, REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2007-01-18 US disclosed
US-20060193816-A1 Methods and compositions for biocidal treatments TERMPRO, LLC 2006-08-31 US disclosed
WO-2006086271-A2 METHODS AND COMPOSITIONS FOR BIOCIDAL TREATMENTS ELFERSY JACQUES (US) 2006-08-17 WO disclosed
EP-1545798-A4 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHOD OF MAKING SAME US GOV HEALTH & HUMAN SERV (US) 2006-06-14 EP disclosed
US-20060110351-A1 Use of silanes on cosmetic agents and methods for treating hair ITN NANOVATION AG (DE) 2006-05-25 US disclosed
EP-1555990-A1 USE OF SILANES IN COSMETIC AGENTS AND METHODS FOR TREATING HAIR ITN NANOVATION GMBH (DE) 2005-07-27 EP disclosed
EP-1545798-A1 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHOD OF MAKING SAME THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2005-06-29 EP disclosed
EP-1436018-A1 NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2004-07-14 EP disclosed
US-6762172-B1 ANTIMICROBIAL SILANE CONTAINING A HYDROLYZABLE GROUP AND OPTIONALLY A NONHYDROLIZABLE ORGANIC GROUP, AN ORGANIC CARBONATE STABILIZER; NONHYDROLIZING SHELF STABLE SOLUTION NOVA BIOGENETICS, INC. 2004-07-13 US disclosed
WO-2004012874-A1 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHOD OF MAKING SAME THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2004-02-12 WO disclosed
WO-2004012691-A1 USE OF SILANES IN COSMETIC AGENTS AND METHODS FOR TREATING HAIR ITN NANOVATION GMBH (DE) 2004-02-12 WO disclosed
US-6632805-B1 With polyol containing at least three hydroxy groups and is not hydroxyethyl cellulose; treating food or medical articles EMORY UNIVERSITY 2003-10-14 US disclosed
US-20030180440-A1 Ether-stabilized organosilane compounds and methods for using the same ELFERSY JACQUES E (US) 2003-09-25 US disclosed
WO-2003026717-A1 NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2003-04-03 WO disclosed
US-6469120-B1 EXTENDED SHELF-LIFE, WATER-STABLE ORGANOSILANE COMPOUNDS, PRODUCTS AND COMPOSITIONS BIOSHIELD TECHNOLOGIES, INC. 2002-10-22 US disclosed
EP-0853482-A4 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE UNIV EMORY (US) 2002-07-31 EP disclosed
US-6221944-B1 SURFACE TREATMENT EMORY UNIVERSITY 2001-04-24 US disclosed
US-6120587-A Water-stabilized organosilane compounds and methods for using the same BIOSHIELD TECHNOLOGIES, INC. (US) 2000-09-19 US disclosed
US-6113815-A HYDROLYSIS RESISTANCE BIOSHIELD TECHNOLOGIES, INC. (US) 2000-09-05 US disclosed
EP-1006136-A1 Solid-liquid phase interfacial polymerisation DOW CORNING CORPORATION (US) 2000-06-07 EP disclosed
EP-0996625-A1 WATER-STABILIZED ORGANOSILANE COMPOUNDS AND THEIR USE Bioshield Technologies, Inc. (US) 2000-05-03 EP disclosed
EP-0996624-A1 WATER-STABILIZED ORGANOSILANE COMPOUNDS AND METHODS FOR USING THE SAME Bioshield Technologies, Inc. (US) 2000-05-03 EP disclosed
US-6046293-A Solid-liquid phase interfacial polymerization UNIVERSITY OF SOUTH AUSTRALIA (AU) 2000-04-04 US disclosed
US-5959014-A A REACTION PRODUCT OF AN ORGANOSILANE COMPOUND AND A POLYOL COMPOUND FOR TREATING VARIOUS SUBSTRATES; NON-TOXIC, NON-FLAMMABLE, SIMPLE, ECONOMICAL AND ARE OPERABLE OVER A WIDE VARIETY OF PH RANGES; ANTIMICROBIAL PROTECTIVE COATINGS EMORY UNIVERSITY (US) 1999-09-28 US disclosed
US-5954869-A Water-stabilized organosilane compounds and methods for using the same BIOSHIELD TECHNOLOGIES, INC. (US) 1999-09-21 US disclosed
WO-1999003865-A1 WATER-STABILIZED ORGANOSILANE COMPOUNDS AND METHODS FOR USING THE SAME BIOSHIELD TECHNOLOGIES, INC. (US) 1999-01-28 WO disclosed
WO-1999003866-A1 WATER-STABILIZED ORGANOSILANE COMPOUNDS AND THEIR USE BIOSHIELD TECHNOLOGIES, INC. (US) 1999-01-28 WO disclosed
EP-0877027-A2 Water-stabilized organosilane compounds and methods for using the same Bioshield Technologies, Inc. (US) 1998-11-11 EP disclosed
EP-0853482-A1 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE EMORY UNIVERSITY (US) 1998-07-22 EP disclosed
US-5726336-A REACTING A BENZENE COMPOUND WITH A VINYLCHLOROSILANE COMPOUND IN THE PRESENCE OF A LEWIS ACID CATALYST; INTERMEDIATES FOR SILICONE POLYMERS USEFUL AS EMULSIONS, GREASES, ADHESIVES, SEALANTS, COATINGS, IN AUTOMOTIVE AND ENGINEERING FIELDS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1998-03-10 US disclosed
WO-1997041876-A1 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE EMORY UNIVERSITY (US) 1997-11-13 WO disclosed
WO-1997041729-A1 METHODS FOR USING WATER-STABILIZED ORGANOSILANES EMORY UNIVERSITY (US) 1997-11-13 WO disclosed
EP-0799851-A2 Preparation of polyorganosilloxanes by interfacial polymerization DOW CORNING CORPORATION (US) 1997-10-08 EP disclosed
US-5629401-A Preparation of polyorganosiloxanes by interfacial polymerization DOW CORNING CORPORATION (US) 1997-05-13 US disclosed
US-5629401-A Preparation of polyorganosiloxanes by interfacial polymerization DOW CORNING CORPORATION (US) 1997-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070087025-A1 Reiteratively layered medical devices and method of preparing same NOS2, NOS1, NOS3 CYP1A2 120/4885CYP2A6 728/4885TAAR1 222/4885
US-20100184724-A1 COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF METAL IONS FABP2, SLC3A2, SLC40A1 CYP1A2 2479/4885CYP2A6 2873/4885TAAR1 401/4885
US-20070237901-A1 Water-Stabilized Antimicrobial Organosilane Products, Compositions, and Methods for Using the Same QARS1, AAAS, LSS CYP1A2 3069/4885CYP2A6 2320/4885TAAR1 2209/4885
US-20060193816-A1 Methods and compositions for biocidal treatments PIK3C3, TET2, CUTA CYP1A2 2380/4885CYP2A6 2708/4885TAAR1 4330/4885
US-20070065475-A1 Methods and compositions for antimicrobial surfaces SIGLEC7, EPCAM, BSG CYP1A2 3784/4885CYP2A6 3434/4885TAAR1 3062/4885
US-20090074971-A1 Water-Stabilized Antimicrobial Organosilane Compositions, and Methods for Using the Same QARS1, LSS, ASNS CYP1A2 2825/4885CYP2A6 2314/4885TAAR1 1882/4885
US-20090069270-A1 Methods for Diluting Water-Stabilized Antimicrobial Organosilane Compositions QARS1, ASNS, LSS CYP1A2 2446/4885CYP2A6 1873/4885TAAR1 3439/4885
US-20120064022-A1 CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF PIEZO1, DSC1, PFAS CYP1A2 4097/4885CYP2A6 4470/4885TAAR1 1980/4885
US-20090203644-A1 Compositions for treating and/or preventing diseases characterized by the presence of metal ions APP, PSEN1, IAPP CYP1A2 4875/4885CYP2A6 4686/4885TAAR1 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.